Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metabolic-associated Fatty Liver Disease”

277 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 277 results

Not applicableUnknownNCT06503068
What this trial is testing

Impact of NAFLD vs MAFLD Stigma on Quality of Life in Egyptian Patients

Who this might be right for
NAFLD
Tanta University 500
Not applicableLooking for participantsNCT07400367
What this trial is testing

Impact of a Probiotic Supplementation With Lifestyle Modification on Liver Steatosis, Fibrosis, and Metabolic Health in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

Who this might be right for
Liver ElastographyLiver SteatosisLiver Function Test+2 more
Fu Jen Catholic University Hospital 80
Large-scale testing (Phase 3)Looking for participantsNCT06632457
What this trial is testing

LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis

Who this might be right for
Metabolic Dysfunction Associated Steatohepatitis
Boehringer Ingelheim 1,590
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07310407
What this trial is testing

Rutin and Vitamin C in Patients With Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD)

Who this might be right for
NAFLD
Ain Shams University 120
Not applicableNot Yet RecruitingNCT07730853
What this trial is testing

Isocaloric Navy-Bean Substitution in Adults With MASLD

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)Liver FibrosisMetabolic Dysfunction-Associated Steatohepatitis (MASH)
Icahn School of Medicine at Mount Sinai 40
Not applicableLooking for participantsNCT05546086
What this trial is testing

BeijngFH Health Cohort Study

Who this might be right for
Non-Alcoholic Fatty Liver Disease
Beijing Friendship Hospital 8,103
Testing effectiveness (Phase 2)Looking for participantsNCT07481734
What this trial is testing

Tesamorelin for Reduction of Liver Fat in Adults With Fatty Liver Disease (Mock Study)

Who this might be right for
Metabolic Associated Steatotic Liver DiseaseNonalcoholic SteatohepatitisHepatic Steatosis
Hudson Biotech 120
Not applicableNot Yet RecruitingNCT06773221
What this trial is testing

The Efficacy and Safety of Chiglitazar in Patients with MAFLD-related Cirrhosis

Who this might be right for
Metabolic Dysfunction Associated Fatty Liver DiseaseCompensated Liver Cirrhosis
Beijing Friendship Hospital 195
Not applicableUnknownNCT05738707
What this trial is testing

Clinical Study of SARS-CoV-2 Vaccine in Metabolism-related Fatty Liver Disease

Who this might be right for
Metabolic Associated Fatty Liver Disease
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 100
Not applicableUnknownNCT06061640
What this trial is testing

The Potential Value and Impact of Diagnostic Biomarkers for MAFLD Using Machine Learning Methods

Who this might be right for
Metabolic Dysfunction-associated Fatty Liver Disease
The First Affiliated Hospital of Zhejiang Chinese Medical University 500
Not applicableActive Not RecruitingNCT06503120
What this trial is testing

Nutritional Education Program for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

Who this might be right for
Fatty Liver, NonalcoholicDiet, Healthy
Taichung Veterans General Hospital 78
Post-approval studies (Phase 4)Looking for participantsNCT06989723
What this trial is testing

Pioglitazone and Empagliflozin for Fatty Liver Disease in Type 2 Diabetes

Who this might be right for
Type 2 DiabetesFatty Liver
Seoul National University Bundang Hospital 120
Large-scale testing (Phase 3)Looking for participantsNCT06461208
What this trial is testing

A PROspective Faecal MIcrobiota tranSplantation Trial to Improve outcomEs in Patients With Cirrhosis

Who this might be right for
Liver Cirrhosis
King's College London 300
Not applicableStudy completedNCT06443723
What this trial is testing

Metabolic Dysfunction Associated Fatty Liver Disease in Long-Term Cholecystectomy Patients

Who this might be right for
Liver Steatoses
Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital 149
Not applicableLooking for participantsNCT06274788
What this trial is testing

Safety Study to Evaluate the Occurrence of EFAD in Pediatric Patients With PNAC Who Require More Than Eight Weeks of Omegaven Treatment

Who this might be right for
Parenteral Nutrition Associated Liver Disease (PNALD)Essential Fatty Acid DeficiencyMalnutrition+1 more
Fresenius Kabi 40
Not applicableUnknownNCT05913986
What this trial is testing

Supplementation With Alpha-lipoic Acid and Silybum Marianum(LUDLEV®) for the Improvement of Fatty Liver Disease

Who this might be right for
Metabolic Associated Fatty Liver Disease
Saluz Investigación S. C. 50
Large-scale testing (Phase 3)Study completedNCT02216552
What this trial is testing

Resveratrol for the Treatment of Non Alcoholic Fatty Liver Disease and Insulin Resistance in Overweight Adolescents

Who this might be right for
NAFLDTYPE 2 DIABETESMETABOLIC SYNDROME
University of Manitoba 10
Not applicableLooking for participantsNCT06706856
What this trial is testing

Quantitative Ultrasound to Assess Steatotic Liver Disease in Children

Who this might be right for
MASLDMASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease
University of California, San Diego 120
Not applicableUnknownNCT05421572
What this trial is testing

Epidemiological Survey on Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)

Who this might be right for
Fatty Liver Disease
Beijing Tsinghua Chang Gung Hospital 2,000
Post-approval studies (Phase 4)Looking for participantsNCT07058155
What this trial is testing

Optimizing Portal Hypertension With TIPS and Interval Metabolic Surgery for Advanced Liver Disease

Who this might be right for
Liver CirrhosesPortal Hypertension Related to CirrhosisSevere Obesity+1 more
The Cleveland Clinic 70
Next Page